PP_1170x120_10-25-21

leuprolide acetate for injection

Amneal receives approval for Leuprolide Acetate

Amneal receives approval for Leuprolide Acetate

BRIDGEWATER, N.J. – Amneal Pharmaceuticals announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration for leuprolide acetate for injection. Harsher Singh, SVP for Amneal Biosciences stated, “We are making tremendous progress expanding our injectables business. This latest new product is another key therapeutic for the institutional

Adheris Health